Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
$1.39
+0.7%
$1.36
$1.20
$7.13
$9.41M61.54539,879 shs25,787 shs
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
$6.37
$0.38
$1.24
$26.05M0.91522,308 shs466,373 shs
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$0.73
$0.66
$0.51
$0.99
$9.34M0.035,265 shsN/A
PFHOD
Pacific Health Care Organization
$1.25
-69.5%
$1.25
$1.11
$5.90
$16M0.941,720 shs2,100 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
0.00%+5.38%-1.44%-18.69%+136,999,900.00%
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
0.00%0.00%0.00%0.00%0.00%
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
0.00%0.00%0.00%0.00%0.00%
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%+24.62%+12.31%+4.96%-16.09%
PFHOD
Pacific Health Care Organization
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
2.3909 of 5 stars
0.03.00.00.02.85.01.3
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
N/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
$150K62.74N/AN/A$2.45 per share0.57
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A$1.54 per shareN/A
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$5.63M1.66$0.06 per share11.60$0.84 per share0.87
PFHOD
Pacific Health Care Organization
$6.80M2.35$0.11 per share11.21$0.63 per share1.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
-$14.41M-$3.51N/AN/AN/A-9,873.97%-114.84%-107.19%5/10/2024 (Estimated)
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
-$27.47M-$0.41N/AN/AN/AN/A-27.24%-26.08%N/A
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$770K$0.0514.60N/A13.62%7.12%6.61%5/16/2024 (Estimated)
PFHOD
Pacific Health Care Organization
$1.36MN/A0.00N/A16.87%14.47%12.96%N/A

Latest CLBS, PFHO, PFHOD, BRTX, and GNOW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q4 2023
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/A$0.02+$0.02$0.02N/A$1.64 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
N/AN/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/A
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
N/A
10.72
10.72
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/A
22.33
22.33
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
N/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
11.59
11.59
PFHOD
Pacific Health Care Organization
0.05
12.91
12.91

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
106.77 million5.31 millionNot Optionable
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
2760.58 million59.25 millionOptionable
American Caresource Holdings, Inc. stock logo
GNOW
American Caresource
111N/AN/ANot Optionable
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
3112.80 million4.92 millionNot Optionable
PFHOD
Pacific Health Care Organization
3912.80 millionN/ANot Optionable

CLBS, PFHO, PFHOD, BRTX, and GNOW Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BioRestorative Therapies logo

BioRestorative Therapies

NASDAQ:BRTX
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.
Caladrius Biosciences logo

Caladrius Biosciences

NASDAQ:CLBS
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
American Caresource logo

American Caresource

OTCMKTS:GNOW
American CareSource Holdings, Inc. provides urgent and primary care services in the United States. The company operates healthcare centers that offer non-life-threatening out-patient medical care for the treatment of acute, episodic, and chronic medical conditions. Its healthcare centers provide treatment of general medical problems, including colds, flus, ear infections, hypertension, asthma, pneumonia, urinary tract infections, and other conditions; treatment of injuries, such as fractures, dislocations, sprains, bruises, and cuts; minor non-emergent surgical procedures; diagnostic tests, such as X-rays, electrocardiograms, complete blood counts, and urinalyses; and occupational and industrial medical services, including drug testing, workers' compensation cases, and pre-employment physical examinations. It owns and operates 13 urgent and primary care centers, including 2 in Georgia, 2 in Florida, 3 in Alabama, 4 in North Carolina, and 2 in Virginia. The company was founded in 1995 and is headquartered in Atlanta, Georgia.
Pacific Health Care Organization logo

Pacific Health Care Organization

OTCMKTS:PFHO
Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, lien representation, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves self-administered employers, insurers, third-party administrators, municipalities, and others. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.

Pacific Health Care Organization

OTCMKTS:PFHOD
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third party administrators, municipalities, and others in the United States. The company is involved in managing health care organizations (HCOs) and medical provider networks (MPNs); and negotiating legal agreements for the implementation of workers' compensation carve-outs for California clients/employers with collective bargaining units. It also offers HCO and MPN programs; medical case management services; and ancillary services, including utilization and medical bill review, lien representation, legal support, Medicare set aside, and network access services for workers' compensation claims. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Newport Beach, California.